Clinical Trial Update: A Study Evaluating the Efficacy and Tolerability of Oral Apremilast for the Treatment of Nail Psoriasis [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating oral apremilast for nail psoriasis has completed and posted results on 2021-07-20.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nail Psoriasis
• Psoriasis
• Psoriasis Vulgaris

Drugs mentioned

• OTEZLA (apremilast)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Psoriatic Nail, Psoriasis Vulgaris | Phase 4 | Status: COMPLETED | Results posted: 2021-07-20